Gu, Y., Cao, B. (2026). Real-world study of first-line immunotherapy for EGFR/ALK wild-type advanced NSCLC: Analysis from the China National Cancer Center database.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20584